Stay updated with breaking news from Bxrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, beating the consensus estimate of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Performance BXRX opened at $0.52 on Friday. The business has a 50-day moving average of $0.69 and a two-hundred […]
Baudax Bio (NASDAQ:BXRX – Get Free Report) posted its earnings results on Wednesday. The company reported ($1.49) EPS for the quarter, topping analysts’ consensus estimates of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Down 5.2 % NASDAQ:BXRX traded down $0.03 during midday trading on Thursday, hitting $0.53. The stock had a trading volume […]
Baudax Bio (NASDAQ:BXRX – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($1.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.04) by $0.55, MarketWatch Earnings reports. Baudax Bio Stock Performance NASDAQ BXRX traded down $0.03 during trading hours on Thursday, hitting $0.53. The company had […]
Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 197,700 shares, a decline of 50.1% from the July 15th total of 396,100 shares. Based on an average trading volume of 2,150,000 shares, […]
Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 197,700 shares, a drop of 50.1% from the July 15th total of 396,100 shares. Currently, 2.8% of the shares of the company are short sold. Based […]